tiprankstipranks
Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh (BR:PFIZ34)
:PFIZ34
Brazil Market
PFIZ34
Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh
RESEARCH TOOLSreports

Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh (PFIZ34) Price & Analysis

― Followers

PFIZ34 Stock Chart & Stats

R$34.94
R$0.14(0.40%)
―
--
Day’s Range― - ―
52-Week RangeR$30.45 - R$37.07
Previous CloseN/A
VolumeN/A
Average Volume (3M)5.72K
Market Cap
R$797.73B
Enterprise ValueR$977.28K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)34800.0
Beta-0.20
Next Earnings
Nov 03, 2026
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding5,699,674,000
10 Day Avg. Volume5,688
30 Day Avg. Volume5,722
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A

Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh News

Cboe data shows mixed options sentiment in Pfizer with shares down 1.65%
Cboe data shows mixed options sentiment in Pfizer with shares down 1.65%
Cboe data shows mixed options sentiment in Pfizer (PFE), with shares down 44c near $26.61. Options volume roughly...
4d ago
PFE
Trump Trade: President signs EO to split up of childhood vaccines
Trump Trade: President signs EO to split up of childhood vaccines
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by...
5d ago
AZN
EBS
Trump signs EO to split up of childhood vaccines, Bloomberg reports
Trump signs EO to split up of childhood vaccines, Bloomberg reports
President Donald Trump signed an executive order proposing to split the MMR vaccine into separate shots, require separate...
5d ago
AZN
EBS
Cboe data shows mixed options sentiment in Pfizer with shares up 1.1%
Cboe data shows mixed options sentiment in Pfizer with shares up 1.1%
Cboe data shows mixed options sentiment in Pfizer (PFE), with shares up 30c, or 1.1%, near $27.05. Options...
5d ago
PFE
Cboe data shows mixed options sentiment in Pfizer with shares up 0.97%
Cboe data shows mixed options sentiment in Pfizer with shares up 0.97%
Cboe data shows mixed options sentiment in Pfizer (PFE), with shares up 26c, or 0.97%, near $26.45. Options...
9d ago
PFE
Trump Trade: U.S. issues 15% duty on products made from polysilicon
Trump Trade: U.S. issues 15% duty on products made from polysilicon
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by...
9d ago
AZN
EBS
Pfizer price target lowered to $31 from $35 at Guggenheim
Pfizer price target lowered to $31 from $35 at Guggenheim
Guggenheim lowered the firm’s price target on Pfizer (PFE) to $31 from $35 and keeps a Buy rating...
9d ago
PFE
Trump admin plans to issue executive order on vaccines, autism, Bloomberg says
Trump admin plans to issue executive order on vaccines, autism, Bloomberg says
Trump administration is planning to issue an executive order on vaccines and autism next week, prompted by the...
9d ago
AZN
EBS
Merck announces Health Canada approval of KEYTRUDA for adults with MIBC
Merck announces Health Canada approval of KEYTRUDA for adults with MIBC
Merck (MRK) announced that KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with enfortumab vedotin, an antibody-drug conjugate, is approved...
11d ago
MRK
PFE
Pfizer price target raised to $27 from $26 at BofA
Pfizer price target raised to $27 from $26 at BofA
BofA raised the firm’s price target on Pfizer (PFE) to $27 from $26 and keeps a Neutral rating...
11d ago
PFE
Pfizer: Improving Fundamentals and Cost Savings Offset by Pipeline Execution Risks; Hold Rating Reiterated with Unchanged $28 Price Target
Pfizer: Improving Fundamentals and Cost Savings Offset by Pipeline Execution Risks; Hold Rating Reiterated with Unchanged $28 Price Target
Analyst Terence Flynn of Morgan Stanley maintained a Hold rating on Pfizer, retaining the price target of $28.00....
11d ago
PFE
Pfizer: Hold Rating Reaffirmed as COVID Headwinds Persist and 12‑Month Price Target Remains Unchanged at $26
Pfizer: Hold Rating Reaffirmed as COVID Headwinds Persist and 12‑Month Price Target Remains Unchanged at $26
Goldman Sachs analyst Asad Haider maintained a Hold rating on Pfizer yesterday and set a price target of...
11d ago
PFE
Pfizer: Mixed Q2 Update and Limited Long‑Term Visibility Keep Hold Rating as Price Target Nudged Up to $27
Pfizer: Mixed Q2 Update and Limited Long‑Term Visibility Keep Hold Rating as Price Target Nudged Up to $27
Jason Gerberry, an analyst from Bank of America Securities, reiterated the Hold rating on Pfizer. The associated price...
11d ago
PFE
Pfizer: Hold Rating Reiterated as Analyst Keeps $28 Price Target Unchanged Amid Balanced Pipeline Prospects and LOE Headwinds
Pfizer: Hold Rating Reiterated as Analyst Keeps $28 Price Target Unchanged Amid Balanced Pipeline Prospects and LOE Headwinds
In a report released yesterday, Terence Flynn from Morgan Stanley maintained a Hold rating on Pfizer, with a...
19d ago
PFE

PFIZ34 FAQ

What was Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh’s price range in the past 12 months?
Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh lowest stock price was R$30.45 and its highest was R$37.07 in the past 12 months.
    What is Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh’s market cap?
    Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh’s market cap is R$797.73B.
      When is Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh’s upcoming earnings report date?
      Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh’s upcoming earnings report date is Nov 03, 2026 which is in 79 days.
        How were Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh’s earnings last quarter?
        Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh released its earnings results on Aug 04, 2026. The company reported R$0 earnings per share for the quarter, the consensus estimate of N/A by R$0.
          Is Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh overvalued?
          According to Wall Street analysts Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh pay dividends?
            Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh does not currently pay dividends.
            What is Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh’s EPS estimate?
            Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh have?
            Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh has 5,699,674,000 shares outstanding.
              What happened to Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh’s price movement after its last earnings report?
              Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh reported an EPS of R$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went up 2.207%.
                Which hedge fund is a major shareholder of Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh?
                Currently, no hedge funds are holding shares in BR:PFIZ34
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Pfizer Inc Shs Unsponsored Brazilian Depository Receipts Repr 0.25 Sh (PFIZ34) Earnings & Revenues

                  Historic Earnings Reports
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  ABTT34
                  Abbott Laboratories Shs Unsponsored Brazilian Depository Receipts Repr 0.083333333 S
                  ―
                  ―
                  AMGN34
                  Amgen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.03571 Sh
                  ―
                  ―
                  BMYB34
                  Bristol-Myers Squibb Company Shs Unsponsored Brazilian Depository Receipt Repr 1 Sh
                  ―
                  ―
                  GILD34
                  Gilead Sciences, Inc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh
                  ―
                  ―
                  VRTX34
                  Vertex Pharmaceuticals Incorporated Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh
                  ―
                  ―
                  Compare BR:PFIZ34 Stocks >
                  Popular Stocks